1Baldwin CM, Griffith KA, Nieto FJ, et al. The association ofsleep-disor- dered breathing and sleep symptoms with quality oflife in the Sleep Heart Health Study. Sleep,2001,24:96-105.
2Hale CS. Obstructivesleep apnea and cardiovascular disease andmortality : the argument for causality. J lnsur Med ,2005,37:272.
4Petri N, Svanhlt P, Solw B, et al. Mandibular advancement appliance for obstructive sleep apnoea:re-suhs of a randomised placebo controlled tri- alusing par-allel group design. J Sleep Res ,2008,17:221-229.
6Liu Y, Lowe AA, Fleetham J, et al. Cephalometric andphysiologic predic- tors for the efficacy of an adjustable oral appli-ance used for the treatment of obstructive sleep apnea. Am J Orthod Dentotac Orthop,2001,120:639- 647.
8Barnes M, Houston D,Worsnop C J, et al. A Randomizedcontrolled trial of continuous positive airway pressure inmild obstructive sleep apnea. Am J Respir Crit Care Med,2002,165:773-780.
9Devouassoux G, L6vy P, Rossini E, et al. Sleep apneais associated with bronchial inflammation andcontinuous positive airway pressure-induced airwayhyperresponsivenes. J Allergy Clin Immunol, 2007,119 : 597-603.
10Baltzan MA, Elkholi O, Wolkove N, et al. Evidence ofinterrelated side effects with reduced compliance inpatients treated with nasal continuous positive airwaypressure. Sleep Med ,2009,10 : 198-205.
